Medical Director - Pathologist

Labcorp•Baltimore, MD

1d•$290,000 - $320,000•Onsite

About The Position

Labcorp is a global leader in laboratory services, providing the insights and answers that help healthcare providers, patients, researchers, pharmaceutical companies and health systems make confident decisions and improve outcomes. Through our unparalleled science, data, technology and laboratory network, we advance diagnostics, accelerate innovation and help address some of the world’s most important health challenges. As we shape the future of healthcare, we are leveraging advanced technologies, intelligent digital solutions and data-driven innovation across our operations to enhance how work gets done and deliver greater value to customers and patients. With our global scale and deep expertise, you’ll have the opportunity to do meaningful work, grow your career and make a real impact on people’s health around the world. Together, we’re improving health and improving lives. PGDx by Labcorp is seeking a Medical Director - Pathologist to join our team in Baltimore, MD. Work Schedule: Monday - Friday, 1st shift

Requirements

MD or DO degree from an accredited institution
Board certification in Anatomic Pathology by the American Board of Pathology
Fellowship training in Molecular Genetic Pathology (MGP) or equivalent advanced molecular diagnostics training.
3 or more years years of post-training practice experience in anatomic pathology and/or molecular pathology.
3 or more years of experience practicing in a CLIA-certified, CAP-accredited high-complexity molecular diagnostics laboratory.
2 or more years of experience interpreting and reporting molecular oncology testing, including NGS-based genomic profiling, liquid biopsy, or related precision oncology assays.
2 or more years in development, verification, validation, or implementation of at least one clinical molecular oncology assay.
Eligibility for medical licensure in Maryland and New York and for all credentialing and privileging required for assigned clinical duties.
Track record of scholarly contributions demonstrated through peer-reviewed publications, national presentations, clinical studies, translational research, guideline development, or evidence-generation programs. 5 or more peer-reviewed publications or equivalent scholarly contributions.
Experience in laboratory, programmatic, or medical leadership experience within a molecular diagnostics, precision oncology, or pathology service.
Demonstrated scholarship in an anatomic pathology subspecialty through research, publications, presentations, or collaborative projects
Clinical expertise in anatomic pathology, molecular oncology, tissue assessment, and precision oncology testing.
Knowledge of CLIA, CAP, federal, state, quality, accreditation, and compliance requirements applicable to assigned responsibilities.
Ability to provide medical leadership across clinical operations, assay development, validation, studies, and product launches.
Clear written and verbal communication with laboratory teams, clinicians, customers, investigators, and strategic partners.
Strong collaboration, professionalism, accountability, sound judgment, and commitment to patient care and quality.
Ability to manage priorities in a growing, high-complexity oncology laboratory while protecting turnaround time and business continuity.

Nice To Haves

3 or more years of experience practicing in oncology or precision oncology diagnostics organization.
3 or more years’ experience with solid-tumor NGS, comprehensive genomic profiling, liquid biopsy, MRD testing, digital pathology, histology quality control, or biomarker testing.
3 or more years’ experience with assay validation, clinical studies, evidence generation, companion diagnostics, biopharma-sponsored research, product launches, or commercial medical support.
2 or more years of experience with liquid biopsy, ctDNA, MRD, or blood-based oncology testing.
3 or more years of experience supporting assay development, validation, product launch, or clinical implementation of molecular diagnostics.
3 or more years of experience with advanced molecular platforms, including RNA sequencing, whole transcriptome sequencing, whole-exome sequencing, multi-omic analyses, biomarker discovery, or AI-enabled precision oncology applications.

Responsibilities

Review, interpret, and sign out tissue- and blood-based precision oncology cases in a timely manner.
Provide on-site medical coverage and medical oversight for the Baltimore laboratory and the PGDx testing portfolio, including Plasma Complete, Plasma Detect, elio tissue complete (ETC), and elio plasma focus (EPF).
Perform tissue adequacy review and quality control for PGDx assays, OmniSeq INSIGHT, Plasma Detect Genome, and future oncology assays, including landmark tissue assessment for tumor-informed MRD testing.
Provide pathology leadership for Plasma Detect Genome V2 development and launch, including tissue quality-control processes, clinical validation, evidence-generation studies, and operational readiness.
Provide pathology consultation for challenging specimens, test selection, case triage, and medical or technical questions.
Support assay development, verification, validation, product enhancement, and launch activities for precision oncology products.
Provide pathology leadership for clinical studies, evidence-generation programs, companion diagnostic activities, and biopharma collaborations.
Contribute to study design, data interpretation, abstracts, presentations, peer-reviewed publications, and scientific meetings.
Support quality systems, SOP development and review, quality metrics, proficiency and competency activities, investigations, corrective and preventive actions, accreditation requirements, laboratory inspections, and regulatory compliance.
Collaborate with Medical Affairs, R&D, bioinformatics, digital pathology, data science, Operations, Quality, Commercial, marketing, customer service, and clinical teams.
Provide medical and scientific support for provider inquiries, field education, product positioning, medical messaging, launch readiness, customer engagement, molecular tumor boards, webinars, and clinical outreach.
Build effective relationships with external physicians, investigators, customers, and strategic partners.
Identify and implement improvements to tissue workflows, digital pathology processes, turnaround time, consistency, scalability, business continuity, and clinical quality.